arginyl-glycyl-aspartyl-serine has been researched along with Blood Clot in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, N; Peng, S; Wang, C; Zhao, M | 1 |
| Bi, L; Bi, W; Cai, J; Fischer, NO; Liu, S; Peng, S; Tok, JB; Wang, G | 1 |
| Gui, L; Li, Z; Peng, S; Wang, X; Wang, Y; Wu, J; Zhang, X; Zhao, M; Zhao, S; Zheng, M | 1 |
| Chen, S; Liang, M; Wang, Y; Wu, C; Zhang, X; Zhao, M | 1 |
| Ao, M; Guo, D; Wang, Z; Zhang, Y; Zheng, Y; Zhou, J | 1 |
| Castellanos, MI; Díaz-Ricart, M; Escolar, G; Gil, FJ; Ginebra, MP; Guillem-Marti, J; Manero, JM; Mas-Moruno, C; Pegueroles, M | 1 |
| Bagnell, CR; Campbell, RA; Overmyer, KA; Wolberg, AS | 1 |
| Ayoufu, G; Li, L; Mu, Y | 1 |
| Bin, JP; Hao, R; Liu, J; Liu, YL; Ou, WC; Xie, JG; Xiu, JC; Zha, DG | 1 |
| Carpen, O; Lassila, R; Siljander, P | 1 |
| Ahn, YS; Horstman, L; Jy, W; Mao, WW; Tao, J | 1 |
| Mohri, H | 1 |
1 review(s) available for arginyl-glycyl-aspartyl-serine and Blood Clot
| Article | Year |
|---|---|
[RGD-dependent and -independent binding domains of fibronectin to GPIIb/IIIa].
Topics: Fibrinogen; Fibronectins; Oligopeptides; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1997 |
11 other study(ies) available for arginyl-glycyl-aspartyl-serine and Blood Clot
| Article | Year |
|---|---|
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
Topics: Animals; Carbolines; Cell Adhesion; Disease Models, Animal; Fibrinolytic Agents; Humans; Male; Oligopeptides; Platelet Aggregation; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship; Thrombosis; Tumor Cells, Cultured | 2002 |
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
Topics: Adenosine Diphosphate; Animals; Carbolines; Drug Design; Fibrinolytic Agents; Free Radical Scavengers; Hydrogen; Molecular Structure; Oligopeptides; PC12 Cells; Phenol; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Thrombosis | 2006 |
Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor.
Topics: Administration, Oral; Animals; Binding Sites; Blood Platelets; Drug Design; Microscopy, Atomic Force; Molecular Docking Simulation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Structure, Tertiary; Rats; Stereoisomerism; Thermodynamics; Thiazoles; Thrombosis | 2017 |
Poly-
Topics: Animals; Fibrinolytic Agents; Porifera; Rats; Thrombolytic Therapy; Thrombosis; Urokinase-Type Plasminogen Activator | 2023 |
Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus.
Topics: Drug Compounding; Gadolinium; Humans; In Vitro Techniques; Lactic Acid; Magnetic Resonance Imaging; Nanocapsules; Oligopeptides; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Binding; Reproducibility of Results; Sensitivity and Specificity; Surface Properties; Thrombosis | 2013 |
Cell adhesive peptides functionalized on CoCr alloy stimulate endothelialization and prevent thrombogenesis and restenosis.
Topics: Blood Platelets; Chromium Alloys; Coated Materials, Biocompatible; Graft Occlusion, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Oligopeptides; Thrombosis | 2017 |
Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.
Topics: Cell Membrane; Cells, Cultured; Factor Va; Factor Xa; Fibrin; Fibrinogen; Fibroblasts; Humans; In Vitro Techniques; Integrins; Microscopy, Confocal; Microscopy, Electron, Transmission; Oligopeptides; Prothrombin; Thrombin; Thrombosis | 2008 |
Experimental study of the preparation of targeted microbubble contrast agents carrying urokinase and RGDS.
Topics: Animals; Contrast Media; Drug Carriers; Fibrinolytic Agents; Microbubbles; Oligopeptides; Rabbits; Sonication; Thrombosis; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2009 |
[Targeted adhesion of platelet receptor-specific microbubble agent to thrombus in vitro].
Topics: Cell Adhesion; Drug Delivery Systems; Humans; Microbubbles; Oligopeptides; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ultrasonography | 2005 |
Platelet-derived microparticles associate with fibrin during thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Biomarkers; Blood Coagulation; Blood Platelets; Calcimycin; Calcium; Collagen; Fibrin; Fibrinogen; Humans; Ionophores; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Molecular Sequence Data; Oligopeptides; P-Selectin; Perfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Thrombosis; von Willebrand Factor | 1996 |
Platelet microparticles bind, activate and aggregate neutrophils in vitro.
Topics: Blood Platelets; Calcium; Cell Adhesion; Cell Aggregation; Cell Communication; Chelating Agents; Egtazic Acid; Hemostasis; Humans; Macrophage-1 Antigen; Microscopy, Fluorescence; Neutrophils; Oligopeptides; P-Selectin; Phagocytosis; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Thrombosis | 1995 |